Research & Innovation - Participant Portal


TOPIC : Bioactive compounds from meso-organism's bioconversion

Topic identifier: BBI.VC3.R8
Publication date: 09 July 2014

Types of action: BBI-RIA Bio-based Industries Research and Innovation action
Opening date:
09 July 2014
Deadline: 15 October 2014 17:00:00

Time Zone : (Brussels time)
  Horizon 2020
Topic Description

Specific challenge: Due to their nutritional and functional properties, bioactive compounds (e.g. specific carbohydrates, peptides or lipids) find important markets in human and animal nutraceuticals, food additives and cosmetics. Their production poses two main challenges: (i) although found in nature, many are only present at very low levels, so that massive land usage is needed to obtain sufficient amounts; moreover, the quality of harvested material is not constant. (ii) chemical production processes (as for chitosan) are associated with a high environmental impact.

Meso-organisms have been proven able to convert agro-based residues (e.g. cereal residues, sugar residues or oil rich plant residues) into unique highly bioactive protein-rich, lipid-rich and chitin-rich bioactive compounds with very high efficiency (higher than any other known eukaryotic organism) and lower costs than micro-organism-based technologies. However the development of such process is not yet fully established and resulting products still need improvements to meet the requirements of the mentioned markets, in particular concerning safety for the customers.

Scope: Development of breakthrough approaches to obtain sustainable bioactive compounds from agro-based residues through bioconversion of meso-organisms (i.e. terrestrial invertebrates), mild recovery, functionalization and activation. Research should focus on high value products, rather than commodities. Targeted applications of chitins, lipids and bioactive peptides include nutraceuticals, food additives and cosmetics markets. A life-cycle assessment should be carried out in order to evaluate the environmental and socio-economic performance of the developed products. Proposals should address full risk assessment, including HACCP, regulatory implications (e.g. market authorisation), contaminant analysis, allergy and exposure analysis based on consumption and use data.

It is considered that proposals with a total eligible budget of at least EUR 2 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals with another budget.

Expected impact:

         Increasing value for agro-based residues compared to their current application by the conversion to new higher value functional products.

         Opening of new markets for chitin, peptides and fatty acids and making available new nutraceutical and cosmetic components with enhanced bioactive properties (e.g. antimicrobial and antifungi)

         Delivering bioactive compounds with an increase of 10% in bioactivity with respect to similar products and a 25% reduction in environmental impact (GHG emissions, water pollution) as compared to conventional fatty acid or chitosan production.

Enabling the mobilisation of currently unused sidestreams and reducing the import of materials (e.g. chitosan).

Topic conditions and documents

Please read carefully all provisions below before the preparation of your application.

  1. List of countries and applicable rules for funding: described in part A of the Annex of the BBI JU Annual Work Plan 2014.
  2. Eligibility and admissibility conditions: described in part B of the Annex of the BBI JU Annual Work Plan 2014.
  3. Evaluation

    3.1  Evaluation criteria and procedure, scoring and threshold: described in part F of the Annex of the BBI JU Annual Work Plan 2014.

    3.2 For submission and evaluation process, see the H2020 Guide to the submission and evaluation process and the BBI JU Calls 2014 - Guide for applicants.
  4. Proposal page limits and layout: Please refer to Part B of the standard proposal template.
  5. Indicative timetable for evaluation and grant agreement:
    Information on the outcome of one-stage evaluation: maximum 5 months from the final date for submission.
    Signature of grant agreements: maximum 3 months from the date of informing successful applicants.

  6. Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:

    BBI Research and Innovation Action (BBI-RIA):

    Specific provisions and funding rates: described in part D of the Annex of the BBI JU Annual Work Plan 2014.
    Standard proposal template
    Standard evaluation form
    BBI JU Model Grant Agreement
    H2020 Annotated Model Grant Agreement
  7. Additional provisions:

    Technology readiness levels (TRL): described in part E of the Annex of the BBI Annual Work Plan.
  8. Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
  9. BBI additional documents:
    BBI JU Call fiche 2014
    BBI JU Work Plan 2014
    BBI JU Scientific Innovation and Research Agenda (SIRA)
    Horizon 2020 Rules for participation
    BBI-JU derogation to H2020 Rules for Participation
    BBI JU – Regulation of establishment


Additional documents

  • Information on selected projects of the call 2014 en
  • Biobased Industries Joint Undertaking FAQ on Financing Rules en

Submission Service

No submission system is open for this topic.

Get support

Participant Portal FAQ – Submission of proposals

National Contact Points (NCP) – contact your NCP for further assistance.

Enterprise Europe Network – contact your EEN national contact point for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.

Research Enquiry Service – ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.

IT Helpdesk – contact the Participant Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.

Ethics – to ensure compliance with ethical issues, further information is available on the Participant Portal and on the Science and Society Portal.

European IPR Helpdesk assists you on intellectual property issues.

The European Charter for Researchers and the Code of Conduct for their recruitment

CEN and CENELEC, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at

Partner Search Services helps you find a partner organisation for your proposal.

H2020 Funding Guide your online guide on the procedures from proposal submission to managing your grant.